Evaluation of sample preparation and chromatographic separation for the parallel determination of taurine and edaravone in rat tissues using HILIC-MS/MS

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2015-04-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00216-015-8635-0PMID 25855151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two complementary liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods to study the excretion and metabolic interaction of edaravone and taurine in rats.

  2014cited by this paper
• LC-MS/MS methods for the determination of edaravone and/or taurine in rat plasma and its application to a pharmacokinetic study.

  2014influential reference
• Development and application of a LC-MS/MS assay for the simultaneous quantification of edaravone and taurine in beagle plasma.

  2013cited by this paper
• Optimization and validation of a CE-LIF method for amino acid determination in biological samples.

  2013cited by this paper
• Taurine and central nervous system disorders

  2012cited by this paper
• A HILIC-MS/MS method for the simultaneous determination of seven organic acids in rat urine as biomarkers of exposure to realgar.

  2012cited by this paper
• APPLICATION OF 2,4-DINITROFLUOROBENZENE PRE-COLUMN DERIVATIZATION TO QUANTITATIVE DETERMINATION OF TAURINE AND ITS INTERMEDIATE IN BEVERAGES AND MILK SAMPLES

  2012cited by this paper
• Rapid and reliable quantitation of amino acids and myo-inositol in mouse brain by high performance liquid chromatography and tandem mass spectrometry.

  2012cited by this paper
• II. Cerebral infarction/transient ischemic attack (TIA).

  2011cited by this paper
• Determination of taurine in biological samples by high-performance liquid chromatography using 4-fluoro-7-nitrobenzofurazan as a derivatizing agent.

  2011cited by this paper
• A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

  2011cited by this paper
• Quantitative determination of taurine and related biomarkers in urine by liquid chromatography–tandem mass spectrometry

  2011cited by this paper
• Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats

  2010cited by this paper
• Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.

  2010cited by this paper
• Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.

  2009cited by this paper
• Enhancing the Determination of Sulfonic Acids using Anion‐Exchange Chromatography with Post‐Column Derivatization and Spectrometric Detection

  2008cited by this paper
• In vitro metabolism study of edaravone in Wistar and hairless rat skin.

  2008cited by this paper
• Neuroprotective Mechanism of Taurine due to Up-regulating Calpastatin and Down-regulating Calpain and Caspase-3 during Focal Cerebral Ischemia

  2008cited by this paper
• Hydrophilic interaction chromatography.

  2008influential reference
• Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications

  2007cited by this paper
• Hydrophilic interaction chromatography.

  2006cited by this paper
• Mode of action of taurine as a neuroprotector.

  2005cited by this paper
• Bioanalytical Method Validation

  2004cited by this paper
• Separation methods for taurine analysis in biological samples.

  2002cited by this paper
• Long‐lasting enhancement of corticostriatal neurotransmission by taurine

  2002cited by this paper
• Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress.

  2000cited by this paper
• Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia.

  1997cited by this paper
• Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one.

  1996cited by this paper
• Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.

  1994cited by this paper
• Review: myocardial physiological effects of taurine and their significance.

  1992cited by this paper
• Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.

  1988cited by this paper
• TAURINE DISTRIBUTION IN CAT BRAIN

  1972cited by this paper

• Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex

  2024cites this paper
• Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability.

  2023cites this paper
• Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704

  2021influential citation
• Design, Synthesis, Chemistry and Biological Evaluation of Some Polyfunctional Heterocyclic Nitrogen Systems—Overview

  2020cites this paper
• Simultaneous Determination of Caffeine, Taurine and Five Water-Soluble Vitamins in Tobacco Products by HPLC–MS/MS

  2019cites this paper
• Recent applications of hydrophilic interaction liquid chromatography in pharmaceutical analysis.

  2017cites this paper